Nom du produit:4-Hydroxy-6-oxo-1-[3-(trifluoromethyl)phenyl]-1,6-dihydro-3-pyridazinecarboxylic acid

IUPAC Name:4-hydroxy-6-oxo-1-[3-(trifluoromethyl)phenyl]-1,6-dihydropyridazine-3-carboxylic acid

CAS:121582-64-7
Formule moléculaire:C12H7F3N2O4
Pureté:95%
Numéro de catalogue:CM164465
Poids moléculaire:300.19

Unité d'emballage Stock disponible Prix($) Quantité
CM164465-1g in stock ǸŮǙ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:121582-64-7
Formule moléculaire:C12H7F3N2O4
Point de fusion:-
Code SMILES:OC(=O)C1=NN(C(=O)C=C1O)C1=CC(=CC=C1)C(F)(F)F
Densité:
Numéro de catalogue:CM164465
Poids moléculaire:300.19
Point d'ébullition:
N° Mdl:MFCD00141002
Stockage:Store at 2-8°C.

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.